• Find Your Perfect MSS 2026 Sessions in the App: Guide by Age of Practice

    March 17, 2026

    Choosing the right classes at Medical Spa Show 2026 can fast-track your next phase of growth. Whether you just opened your med [...]

  • Moxie

    Moxie Raises $25M Series C to Bring Clinical-Grade Operating Infrastructure to Independent Aesthetic Practices

    March 10, 2026

    Moxie, the clinical-grade operating system for aesthetic medicine, announced a $25 million Series C funding round led by Viewpoint Ventures, with participation [...]

  • Allergan Aesthetics, an AbbVie company

    Allergan Aesthetics Releases New Data on Medical Weight Loss Trends and Emerging Aesthetic Needs

    March 4, 2026

    The rapid rise of medical weight loss treatments is driving major shifts in aesthetic patient behavior, with more consumers seeking facial volume [...]

  • Galderma Announces Triple Approval of New State-of-the-art Restylane Syringe in the EU, the U.S. and Canada

    February 25, 2026

    Regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art Restylane syringe for use with its Restylane NASHA [...]

  • We Are All Sculptra: First-of-its-Kind Initiative from Galderma

    February 19, 2026

    Galderma, the pure-play dermatology category leader, unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra [...]

  • Q&A: Merz Aesthetics Celebrates 15 Years of Xeomin (incobotulinumtoxinA) with Campaign Refresh, Sweepstakes

    February 11, 2026

    By Madilyn Moeller, Marketing Content Coordinator, American Med Spa Association (AmSpa)Merz Aesthetics is celebrating 15 years since the U.S. Food and Drug [...]

  • NEW JERSEY Bill Creates Path to Independence for Advanced Practice Nurses

    February 5, 2026

    Bill Name: Senate Bill 2996 (S 2996)  Assembly Bill 4052 (A 4052)Primary Sponsor: S 2996 Senator Joseph Vitale, Senator Troy Singleton      [...]

  • Galderma’s RelabotulinumtoxinA Moves Closer to U.S. Market After FDA Accepts BLA Resubmission

    February 5, 2026

    Galderma announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application (BLA) for RelabotulinumtoxinA, a [...]

  • Medical Spa Show 2026 Headlined by Steven Dayan, MD, Erika Barry, NP-C, and Kay Durairaj, MD

    February 5, 2026

    Dr. Steven Dayan, keynote speaker at AmSpa's Medical Spa Show, April 9 - 12, 2026 at Wynn Las Vegas.Medical Spa Show 2026 [...]

  • Kairos Aesthetic Medicine Opens in Dallas–Fort Worth

    February 4, 2026

    Kairos Aesthetic Medicine, founded by Taylor Siemens, NP-C, has announced its opening in the Dallas–Fort Worth area. The new clinician-led aesthetic and [...]

  • Obagi Medical

    Obagi Launches ALOHA Program with Clinical Contributions from VIO Med Spa, Alpha Aesthetic Partners

    February 3, 2026

    Obagi Medical has launched a large‑scale, practice‑driven clinical initiative designed to gather real‑world evidence on its first FDA‑approved hyaluronic acid filler, Obagi [...]

  • Exosomes, Plasma, and Profit: The Treatment Stack That’s Transforming Aesthetic Practices, Insights From Dr. Chris Croley

    January 16, 2026

    Win Free Exosomes → Simply Register for the Free Exosome Masterclass By MedResultsIn today’s rapidly evolving aesthetic landscape, one reality is becoming [...]